• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡介苗诱导的免疫力与新冠病毒病的发病率和死亡率之间的相关性

Correlation between immunity from BCG and the morbidity and mortality of COVID-19.

作者信息

Wickramasinghe Dakshitha, Wickramasinghe Nilanka, Kamburugamuwa Sohan Anjana, Arambepola Carukshi, Samarasekera Dharmabandhu N

机构信息

Department of Surgery, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.

Department of Physiology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.

出版信息

Trop Dis Travel Med Vaccines. 2020 Aug 28;6:17. doi: 10.1186/s40794-020-00117-z. eCollection 2020.

DOI:10.1186/s40794-020-00117-z
PMID:32868985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7453689/
Abstract

BACKGROUND

To investigate the association between parameters indicating immunity from BCG at country level (presence of BCG vaccination policy, BCG coverage, age-specific incidence of tuberculosis (TB)) and the morbidity and mortality of COVID-19.

METHODS

Country-specific data for COVID-19 cases and deaths, demographic details, BCG coverage and policy, age-specific TB incidence and income level were obtained. The crude COVID-19 cases and deaths per 100,000 population were calculated and assessed against the parameters indicating immunity from BCG using linear regression analysis.

RESULTS

Univariate analysis identified higher income level of a country to be significantly associated with COVID-19 cases ( < 0.0001) and deaths ( < 0.0001) but not with its case fatality rate. The association between COVID-19 and TB was strongest for TB incidence in patients > 65-years (Cases (r = - 0.785, = 0.0001)) and deaths (r = - 0.647, = 0.0001).Multivariate analysis identified the higher income level of a country and not having a universal BCG vaccination policy to affect the COVID-19 cases. The deaths were inversely affected by the presence of BCG vaccination policy and coverage; and positively by the TB incidence in patients > 65-years.

CONCLUSION

Significant inverse correlations observed between cases and deaths of COVID-19 and BCG related parameters highlights immunity from BCG as a likely explanation for the variation in COVID-19 across countries.

摘要

背景

调查国家层面卡介苗免疫相关参数(卡介苗接种政策的存在情况、卡介苗接种覆盖率、特定年龄结核病发病率)与新冠病毒病(COVID-19)的发病率和死亡率之间的关联。

方法

获取各国COVID-19病例和死亡的特定数据、人口统计学详细信息、卡介苗接种覆盖率和政策、特定年龄结核病发病率以及收入水平。计算每10万人口中COVID-19的粗病例数和死亡数,并使用线性回归分析根据卡介苗免疫相关参数进行评估。

结果

单因素分析确定,国家较高的收入水平与COVID-19病例(<0.0001)和死亡(<0.0001)显著相关,但与病死率无关。COVID-19与结核病之间的关联在65岁以上患者的结核病发病率方面最为显著(病例:r = -0.785,P = 0.0001)以及死亡方面(r = -0.647,P = 0.0001)。多因素分析确定,国家较高的收入水平以及没有普遍的卡介苗接种政策会影响COVID-19病例。死亡受到卡介苗接种政策和覆盖率的反向影响;并受到65岁以上患者结核病发病率的正向影响。

结论

COVID-19病例和死亡与卡介苗相关参数之间观察到显著的负相关,这突出表明卡介苗免疫可能是各国COVID-19差异的一个解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de8/7456057/80c4a2d98aff/40794_2020_117_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de8/7456057/ca332329ae70/40794_2020_117_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de8/7456057/26c81177040b/40794_2020_117_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de8/7456057/31837423242f/40794_2020_117_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de8/7456057/282926b2734e/40794_2020_117_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de8/7456057/80c4a2d98aff/40794_2020_117_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de8/7456057/ca332329ae70/40794_2020_117_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de8/7456057/26c81177040b/40794_2020_117_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de8/7456057/31837423242f/40794_2020_117_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de8/7456057/282926b2734e/40794_2020_117_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de8/7456057/80c4a2d98aff/40794_2020_117_Fig5_HTML.jpg

相似文献

1
Correlation between immunity from BCG and the morbidity and mortality of COVID-19.卡介苗诱导的免疫力与新冠病毒病的发病率和死亡率之间的相关性
Trop Dis Travel Med Vaccines. 2020 Aug 28;6:17. doi: 10.1186/s40794-020-00117-z. eCollection 2020.
2
Tuberculosis endemicity and BCG vaccination: Protection against COVID-19.结核病流行和卡介苗接种:预防 COVID-19。
Monaldi Arch Chest Dis. 2022 Jun 24;93(1). doi: 10.4081/monaldi.2022.2281.
3
Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19.环境温度和卡介苗接种覆盖率对 COVID-19 传染性和病死率的全球影响。
PLoS One. 2020 Oct 22;15(10):e0240710. doi: 10.1371/journal.pone.0240710. eCollection 2020.
4
Association of Calmette Guerin Vaccine Strains with COVID-19 Morbidity and Mortality - Evaluation of Global Data.卡介苗菌株与新冠发病率和死亡率的关联——全球数据评估
Indian J Community Med. 2021 Oct-Dec;46(4):727-730. doi: 10.4103/ijcm.IJCM_103_21. Epub 2021 Dec 8.
5
A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.低结核负担国家高危人群中卡介苗接种政策的系统评价:对加拿大土著社区接种策略的启示。
BMC Public Health. 2019 Nov 11;19(1):1504. doi: 10.1186/s12889-019-7868-9.
6
Worldwide inverse correlation between Bacille Calmette-Guérin (BCG) immunization and COVID-19 mortality.全球卡介苗(BCG)接种与 COVID-19 死亡率呈反比关系。
Infection. 2021 Jun;49(3):463-473. doi: 10.1007/s15010-020-01566-6. Epub 2021 Jan 25.
7
Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.BCG 疫苗接种对爱尔兰南部结核病发病的影响。
BMC Infect Dis. 2019 May 9;19(1):397. doi: 10.1186/s12879-019-4026-z.
8
TB infection and BCG vaccination: are we protected from COVID-19?结核感染和卡介苗接种:我们能预防 COVID-19 吗?
Public Health. 2020 Aug;185:91-92. doi: 10.1016/j.puhe.2020.05.042. Epub 2020 May 30.
9
10
Countries with high deaths due to flu and tuberculosis demonstrate lower COVID-19 mortality: roles of vaccinations.高流感和结核病死亡率的国家显示出更低的 COVID-19 死亡率:疫苗的作用。
Hum Vaccin Immunother. 2021 Sep 2;17(9):2851-2862. doi: 10.1080/21645515.2021.1908058. Epub 2021 Apr 15.

引用本文的文献

1
Childhood B cell leukemia: Intercepting the paths to progression.儿童 B 细胞白血病:阻断进展途径。
Bioessays. 2024 Sep;46(9):e2400033. doi: 10.1002/bies.202400033. Epub 2024 Jul 26.
2
BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.BCG 激活训练有素的免疫与接种过 BCG 的人群中诱导产生交叉反应性 COVID-19 抗体有关。
PLoS One. 2024 May 9;19(5):e0302722. doi: 10.1371/journal.pone.0302722. eCollection 2024.
3
Latent Tuberculosis Infection and COVID-19: Analysis of a Cohort of Patients from Careggi University Hospital (Florence, Italy).

本文引用的文献

1
Temperature, Humidity, and Latitude Analysis to Estimate Potential Spread and Seasonality of Coronavirus Disease 2019 (COVID-19).温度、湿度和纬度分析估计 2019 年冠状病毒病(COVID-19)的潜在传播和季节性。
JAMA Netw Open. 2020 Jun 1;3(6):e2011834. doi: 10.1001/jamanetworkopen.2020.11834.
2
Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study.非药物干预措施对 2019 年冠状病毒病和流感在香港的影响评估:一项观察性研究。
Lancet Public Health. 2020 May;5(5):e279-e288. doi: 10.1016/S2468-2667(20)30090-6. Epub 2020 Apr 17.
3
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study.
潜伏性结核感染与2019冠状病毒病:对卡雷吉大学医院(意大利佛罗伦萨)一组患者的分析
Infect Dis Rep. 2023 Dec 10;15(6):758-765. doi: 10.3390/idr15060068.
4
Effectiveness of Bacille Calmette-Guerin vaccination policies in reducing infection and mortality of COVID-19: a systematic review.卡介苗接种政策在降低 COVID-19 感染和死亡率方面的有效性:系统评价。
Glob Health Res Policy. 2022 Nov 7;7(1):42. doi: 10.1186/s41256-022-00275-x.
5
Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens.SARS-CoV-2 抗体与其他病原体、疫苗和食物抗原的反应。
Front Immunol. 2022 Sep 23;13:1003094. doi: 10.3389/fimmu.2022.1003094. eCollection 2022.
6
Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19.虚假的早期生态学关联表明卡介苗接种对 COVID-19 的有效性。
PLoS One. 2022 Sep 20;17(9):e0274900. doi: 10.1371/journal.pone.0274900. eCollection 2022.
7
Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes.多次接种卡介苗预防 1 型糖尿病患者感染 COVID-19 和其他传染病。
Cell Rep Med. 2022 Sep 20;3(9):100728. doi: 10.1016/j.xcrm.2022.100728. Epub 2022 Aug 15.
8
Pathogenesis of SARS-CoV-2 and Coinfection.SARS-CoV-2 的发病机制及合并感染。
Front Immunol. 2022 Jun 16;13:909011. doi: 10.3389/fimmu.2022.909011. eCollection 2022.
9
Association of Calmette Guerin Vaccine Strains with COVID-19 Morbidity and Mortality - Evaluation of Global Data.卡介苗菌株与新冠发病率和死亡率的关联——全球数据评估
Indian J Community Med. 2021 Oct-Dec;46(4):727-730. doi: 10.4103/ijcm.IJCM_103_21. Epub 2021 Dec 8.
10
COVID-19 and Beyond: Exploring Public Health Benefits from Non-Specific Effects of BCG Vaccination.新冠疫情及未来:探索卡介苗接种非特异性效应带来的公共卫生益处。
Microorganisms. 2021 Oct 9;9(10):2120. doi: 10.3390/microorganisms9102120.
控制策略对减少社交接触以控制中国武汉 COVID-19 疫情的效果:建模研究。
Lancet Public Health. 2020 May;5(5):e261-e270. doi: 10.1016/S2468-2667(20)30073-6. Epub 2020 Mar 25.
4
The use of electronic healthcare records for colorectal cancer screening referral decisions and risk prediction model development.利用电子医疗记录进行结直肠癌筛查转诊决策和风险预测模型的开发。
BMC Gastroenterol. 2020 Mar 25;20(1):78. doi: 10.1186/s12876-020-01206-1.
5
The SARS-CoV-2 outbreak: What we know.新型冠状病毒爆发:我们所知道的。
Int J Infect Dis. 2020 May;94:44-48. doi: 10.1016/j.ijid.2020.03.004. Epub 2020 Mar 12.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
8
Global Health Observatory Data Repository.全球卫生观测站数据储存库。
Med Ref Serv Q. 2020 Jan-Mar;39(1):67-74. doi: 10.1080/02763869.2019.1693231.
9
BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design.BCG 诱导的交叉保护和训练免疫的发展:对疫苗设计的启示。
Front Immunol. 2019 Nov 29;10:2806. doi: 10.3389/fimmu.2019.02806. eCollection 2019.
10
Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4 T cell population following BCG immunisation.BCG 免疫后诱导和维持表型异质性肺组织驻留 CD4 T 细胞群体。
Vaccine. 2018 Sep 5;36(37):5625-5635. doi: 10.1016/j.vaccine.2018.07.035. Epub 2018 Aug 7.